Spots Global Cancer Trial Database for International Prospective Registry on Local Treatment Approaches in MLS
The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.
Trial Identification
Brief Title: International Prospective Registry on Local Treatment Approaches in MLS
Official Title: International Prospective Registry on Local Treatment Approaches in Myxoid Liposarcomas
Study ID: NCT04699292
Conditions
Study Description
Brief Summary: To prospectively study commonly used local treatment approaches in Myxoid Liposarcoma (MLS)
Detailed Description: In order to confirm the promising results of the 36 Gy dose level in the DOREMY trial (NCT02106312) and to compare outcome with other local treatment approaches.
Keywords
Eligibility
Minimum Age: 18 Years
Eligible Ages: ADULT, OLDER_ADULT
Sex: ALL
Healthy Volunteers: No
Locations
The Netherlands Cancer Institute, Amsterdam, , Netherlands
Contact Details
Name: Rick Haas, MD/PhD
Affiliation: The Netherlands Cancer Institute
Role: PRINCIPAL_INVESTIGATOR
Take Control of Your Skin and Body Changes Today.
Try out Spots for free, set up only takes 2 mins.
Join others from around the world:
